So You’re Gonna start a patient on ADT

Dr Renu Eapen is a Consultant Urologist in the Genitourinary Oncology service at the Austin Hospital Olivia Newton-John Cancer Centre and the Peter MacCallum Cancer Centre. Dr Eapen undertook research in Female Pelvic Medicine and Reconstructive Surgery at University of Texas Southwestern Dallas. She went on to complete a subspecialty Fellowship at the University of Toronto, Canada and subsequently obtained her robotics and uro-oncology Fellowship at University of California, San Francisco. She is currently undertaking her PhD at the University of Melbourne. Axel Merseburger is Professor of Urology and Chairman of the Department of Urology at University Hospital Schleswig Holstein, Campus Lübeck, in Lübeck, Germany. He was appointed Associate Professor, in 2009, and Professor, in 2012, at Hannover Medical School. He is Principal Investigator for multiple phase 2 and phase 3 clinical trials. Prof. Merseburger is as an advisor for the European Association of Urology (EAU) Guidelines Group for Renal Cancer and has previously served as Chairman of the EAU Guidelines Group for Lasers and Technologies. Prof. Merseburger acts as a reviewer and editorial board member for several urology and oncology indexed journals, is Associate Editor of the World Journal of Urology, and is Editor-in-Chief of European Oncology & Haematology.